Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnancy: A Subgroup Analysis of a Multicenter Real-World Study Involving 1191 Pregnant Women
Background. Real-world evidence of the efficacy and safety of ferric carboxymaltose (FCM) infusion in Indian pregnant women with iron deficiency anemia (IDA) is lacking. Objective. To assess the efficacy and safety of intravenous (IV) FCM in Indian pregnant women with IDA in 4 weeks in a real-life s...
Saved in:
Main Authors: | Prakash Trivedi, S. Chitra, Suma Natarajan, Vandana Amin, Shilpi Sud, Priti Vyas, Meenakshi Singla, Ajinkya Rodge, Onkar C. Swami |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Obstetrics and Gynecology International |
Online Access: | http://dx.doi.org/10.1155/2022/5759740 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
by: Melvin H. Seid, et al.
Published: (2017-01-01) -
The experiences of ferric carboxymaltose desensitization and provocation
by: Fatma Dindar Çelik, MD, et al.
Published: (2025-02-01) -
Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia
by: Iftikhar Hussain, et al.
Published: (2013-01-01) -
Danger of co-administration ferric carboxymaltose and denosumab: hypophosphatemia
by: Aysun Seker, et al.
Published: (2025-01-01) -
REGAIN STUDY: Retrospective Study to Assess the Effectiveness, Tolerability, and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnant Women
by: Saleema Wani, et al.
Published: (2019-01-01)